Cargando…
Cardiovascular biomarkers in COVID-19
Autores principales: | Omland, Torbjørn, Mills, Nicholas L, Mueller, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245137/ https://www.ncbi.nlm.nih.gov/pubmed/34125174 http://dx.doi.org/10.1093/ehjacc/zuab037 |
Ejemplares similares
-
SARS‐CoV‐2 Viremia is Associated With Inflammatory, But Not Cardiovascular Biomarkers, in Patients Hospitalized for COVID‐19
por: Myhre, Peder L., et al.
Publicado: (2021) -
Established Cardiovascular Biomarkers Provide Limited Prognostic Information in Unselected Patients Hospitalized With COVID-19
por: Omland, Torbjørn, et al.
Publicado: (2020) -
Cardiovascular Hospitalizations, Influenza Activity, and COVID-19 Measures
por: Myhre, Peder L., et al.
Publicado: (2020) -
Cardiovascular biomarkers in pregnancy with diabetes and associations to glucose control
por: Jacobsen, Daniel P., et al.
Publicado: (2022) -
Growth Differentiation Factor 15 Provides Prognostic Information Superior to Established Cardiovascular and Inflammatory Biomarkers in Unselected Patients Hospitalized With COVID-19
por: Myhre, Peder L., et al.
Publicado: (2020)